Multiple myeloma (MM) is a malignant hematological tumor caused by abnormal proliferation of plasma cells in the bone marrow, with diverse clinical manifestations often accompanied by complications such as skeletal damage, anemia, and renal impairment. Without timely intervention, ...Learn More

With the advent of the immunotherapy era, PD-L1 drugs have become a focal point for cancer patients and medical practitioners. This article provides an in-depth analysis of the world's most used PD-L1/PD-1 drug list, covering mechanisms of action, clinical effects, and applicable ...Learn More

Prostate cancer is one of the most common malignant tumors in men, with its incidence rising globally, particularly in the context of an increasingly aging population, leading to a growing disease burden. From 2015 to 2025, over this decade, with the rapid development of medical ...Learn More

Gastric cancer, as a globally high-incidence malignant tumor of the digestive tract, has undergone a profound transformation in its diagnostic and treatment models over the past decade, shifting from traditional empirical medicine to precise evidence-based medicine. With ...Learn More

Breast cancer, as one of the most common malignant tumors among women worldwide, has seen its treatment concepts undergo a transformative shift over the past decade from "broad-spectrum comprehensive therapy" to "precision subtype-based therapy." DengyueMed has been deeply engaged ...Learn More